Frontlight ResearchEarly access
CompletedNo phase
Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex Corneas
Key facts
- Who runs it
- AcuFocus, Inc.
- Where
- Philippines and Singapore2 sites in 2 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 45 people enrolled
- Started
- 12 Jul 2022
- Ended
- 28 Nov 2024
- Type of study
- Interventional
- Treatments tested
- IC-8 Intraocular Lens (IOL)
- Record updated
- 19 December 2024
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Minimum 22 years of age
- Able to comprehend and have signed a statement of informed consent
- Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visit(s)
- Planned crystalline lens removal by phacoemulsification, with or without femtosecond laser-assisted extraction, and posterior chamber IOL implantation
- Planned cataract removal or planned clear lens exchange in both eyes
- Potential for postoperative best-corrected distance visual acuity (BCDVA) of 20/32 or better after crystalline lens removal
- Having complex corneas with irregular astigmatism
- Having clear central cornea
- Having best-corrected distance visual acuity (BCDVA) or 20/40 or worse in either eye with or without a glare source (patients with bilateral cataract)
Who cannot take part
- Previous ocular surgery as specified by the protocol
- Use of systemic or ocular medications as specified by the protocol
- Concurrent participation or participation in any clinical investigation up to 30 days prior to preoperative visit
- Presence of ocular abnormalities or conditions (other than corneal irregularities) as specified by the protocol
- Conditions requiring planned ocular surgical intervention
- Severe dry eye or other conditions (such as hormonal fluctuations) that could lead to unstable refraction and/or visual acuity measurements or eye discomfort even with ocular lubricants or dry eye medication
- Requiring an IC-8 IOL outside the available spherical power range
- Pharmacologically dilated pupil size less than 6 mm in either eye
- Preoperative corneal astigmatism >1.50 diopters in the eye to be implanted with the IC-8 IOL
- Active or recurrent anterior segment pathology
- Congenital bilateral cataracts
- Patient is pregnant or nursing
This trial has no sites in United States.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this study is to evaluate the clinical outcomes of the IC-8 IOL implanted in patients with complex corneas after crystalline lens removal.
The group in the trial
- IC-8 IOL GroupTreatment being tested
A monofocal or monofocal toric IOL implanted in the first eye of a subject and the IC-8 IOL implanted in the second eye.
Treatment: IC-8 Intraocular Lens (IOL)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Visual Outcomes Following Cataract Surgery and Implantation of a Small-Aperture Intraocular Lens in Post-Refractive Surgery Patients.Clinical ophthalmology (Auckland, N.Z.), 2026
- Record updated
- 19 December 2024